Tag: Efficacy

Posted on

Chronic Dosing, Cross-Over Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Budesonide Inhalation Aerosol (PT008) Dose 1;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 2;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 3;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 4;   Drug: Placebo
Sponsor:   Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Dexamethasone shows comparable efficacy to prednisone/prednisolone in … – 2 Minute Medicine


2 Minute Medicine

Dexamethasone shows comparable efficacy to prednisone/prednisolone in …
2 Minute Medicine
1. A shorter course of dexamethasone, when compared to longer duration prednisone/prednisolone treatment for pediatric asthma exacerbation, showed no difference in terms of relapse rate. 2. Dexamethasone had a significantly lower incidence of vomiting …

and more »

View full post on asthma – Google News

Posted on

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Beclomethasone dipropionate;   Drug: Placebo;   Drug: albuterol/salbutamol 90 mcg
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Beclomethasone dipropionate;   Drug: Placebo;   Drug: Albuterol/salbutamol
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Indacaterol 27.5 mcg;   Drug: Indacaterol 37.5;   Drug: Indacaterol 55 mcg;   Drug: Indacaterol 75 mcg;   Drug: Indacaterol 150 mcg;   Drug: Placebo
Sponsors:   Novartis;   Novartis Pharmaceuticals
Not yet recruiting – verified October 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days